Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. Total Liabilities 2022–2025
Axsome Therapeutics, Inc. annual total liabilities history from 2022 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Axsome Therapeutics, Inc. total liabilities as of December 31, 2025: 601.5M, a 17.60% increase year-over-year.
- Axsome Therapeutics, Inc. total liabilities for 2025 were 601.5M, a 17.60% increase from 2024.
- Axsome Therapeutics, Inc. total liabilities for 2024 were 511.5M, a 28.75% increase from 2023.
- Axsome Therapeutics, Inc. total liabilities for 2023 were 397.3M, a 79.01% increase from 2022.
- Axsome Therapeutics, Inc. total liabilities for 2022 were 221.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Axsome Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $602 |
| 2024 | $511 |
| 2023 | $397 |
| 2022 | $222 |
Axsome Therapeutics, Inc. Total Liabilities — FAQ
Axsome Therapeutics, Inc. (AXSM) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AXSM's total liabilities history?
The chart and table above show Axsome Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.